Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
SBFMW

Market Cap: $305.86K

SI

Sunshine Biopharma, Inc.

SBFMW

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin32.49%

EBITDA Margin-15.87%

EBIT Margin-16.84%

Pre-tax Margin-16.84%

Net Profit Margin-17.01%

Earnings Yield-7.42%

Valuation Multiples

Price / Book0.04

Price / Sales0.02

Price / Earnings-0.02

PEG-0.00

Forward PEG0.00

EV / Sales-0.15

EV / EBITDA0.95

EV / Operating Cash Flow0.94

EV / Free Cash Flow0.97

Price / Free Cash Flow-0.15

Price / Operating Cash Flow-0.14

Cash Flow & Capital

Free Cash Flow / Share-$11.23

Operating Cash Flow / Share-$11.6

Free Cash Flow Yield-6.63%

Capex / Revenue0.51%

Capex / Operating Cash Flow-3.18%

Capex / Depreciation0.53

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio4.22

Quick Ratio1.98

Cash Ratio1.18

Debt / Assets0.03

Debt / Capital0.03

Debt / Equity0.03

Long-Term Debt / Capital0.00

Debt / Market Cap25.18%

Net Debt / EBITDA1.09

Solvency Ratio-0.89

Financial Leverage1.30

Efficiency & Working Capital

Asset Turnover1.27

Fixed Asset Turnover28.87

Inventory Turnover1.82

Receivables Turnover8.85

Payables Turnover4.69

Days Sales Outstanding41.25

Days Inventory Outstanding200.58

Days Payables Outstanding77.76

Operating Cycle241.83

Cash Conversion Cycle164.08

Working Capital Turnover1.81

Returns & Quality

Return on Equity-25.58%

Return on Assets-21.62%

Return on Invested Capital-20.57%

ROCE-20.76%

Return on Tangible Assets-23.22%

Operating Return on Assets-15.79%

Income Quality0.94

Tax Burden1.01

Interest Burden1.00

Balance Sheet & Intrinsic Metrics

Enterprise Value$-5.34M

Invested Capital$22.05M

Working Capital$18.91M

Tangible Asset Value$19.6M

Net Current Asset Value$18.37M

Graham Net-Net$20.57

Book Value / Share$43.86

Tangible Book Value / Share$39.95

Cash / Share$14.09

Financial Health Scores

Piotroski Score1

Altman Z-Score-22.21

Revenue$27.4M

EBIT$-4.66M

Market Cap$607.85K

Working Capital$18.91M

Retained Earnings$-76.26M

Total Assets$3.15M

Total Liabilities$535.61K